Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tanya Girard"'
Autor:
Louis Bessette, Brandusa Florica, Latha Naik, Dalton Sholter, Pierre-André Fournier, Tanya Girard, Dalinda Liazoghli, Philip A. Baer
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1165-1180 (2024)
Abstract Introduction Rheumatoid arthritis (RA) guidelines recommend methotrexate (MTX)-anchored therapy with biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs); however, tolerability issues often lead to non-adherence.
Externí odkaz:
https://doaj.org/article/e9d2484dcbb84c6ba77f33b2fc8c04bf
Autor:
Louis Bessette, Jonathan Chan, Andrew Chow, Larissa Lisnevskaia, Nicolas Richard, Pierre-Andre Fournier, Dalinda Liazoghli, Tanya Girard, Derek Haaland
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 563-582 (2024)
Abstract Introduction Upadacitinib (UPA), a selective, reversible, oral Janus kinase (JAK)-1 inhibitor, was approved in 2019 in Canada for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). This phase 4 prospective
Externí odkaz:
https://doaj.org/article/1871a11fff06453588ea8eba2d022cb9
Autor:
Stephanie G. Werner, Xenofon Baraliakos, Sabine Reckert, Martin Bohl-Bühler, Marie-Claude Laliberté, Tanya Girard, Katharina Jeromin, Nikola Baschuk, Björn Fritz, Louis Bessette, Axel J. Hueber
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 6, Pp 1503-1518 (2023)
Abstract Introduction Our aim was to investigate the efficacy and safety of upadacitinib (UPA) in patients with either oligo- or polyarticular active psoriatic arthritis (PsA) using routine clinical practice data from an observational, prospective, m
Externí odkaz:
https://doaj.org/article/a787fb929fe14fb9989f5c14f59ca8bb
Autor:
Tanya Girard, Natalie Dayan, Marnie Goodwin Wilson, Miriam Harris, Amira El-Messidi, Sophie Gosselin, David Fleiszer, André Bonnici, Eric Villeneuve, Todd C. Lee, Emily G. McDonald
Publikováno v:
Can Pharm J (Ott)
Background: In the midst of the North American opioid crisis, identifying and intervening on drivers of high-risk opioid prescriptions is an important step towards reducing iatrogenic harm. Objectives: We aimed to identify factors associated with var
Autor:
Eduardo Mysler, Tanya Girard, Pascal Richette, Dario Ponce de Leon, Lisy Wang, Sander Strengholt, Gustavo Citera, Mario H. Cardiel, Jin Kyun Park, Kenneth Kwok, Jose Luis Rivas, Sandra Chartrand, Amit V. Thorat, Hugo Madariaga, Oswaldo Castañeda, Aryeh Fischer
Publikováno v:
Journal of Clinical Rheumatology
Background/objective Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis (RA). Interstitial lung disease (ILD) is an extra-articular manifestation of RA. We investigated incidence rates of ILD in patients with RA,
Autor:
Natalie Dayan, Sophie Gosselin, Christine M. Gunn, Miriam Harris, Tanya Girard, Cristina Longo, Amira El-Messidi, Erica Marrone, Emily G. McDonald, Gabriel D. Shapiro
Publikováno v:
J Obstet Gynaecol Can
Objective We aimed to describe opioid prescribing practices after obstetric delivery and to evaluate how these practices compare with national opioid prescribing guidelines. Methods A closed survey was developed, evaluated for validity and reliabilit
Publikováno v:
Immunology Letters. 161:65-75
CD86 and CD80, the ligands for the co-stimulatory molecules CD28 and CTLA-4, are members of the Ig superfamily. Their structure includes Ig variable-like (IgV) domains, Ig constant-like (IgC) domains and intracellular domains. Although crystallograph
Autor:
Denis Gaucher, Rafick-Pierre Sekaly, Geneviève Beaulé, Oreste Acuto, Frédérique Michel, Tanya Girard, Walid Mourad, Mohamed El-Far
Publikováno v:
Biochemical and biophysical research communications. 423(2)
T cell activation requires both antigen specific and co-stimulatory signals that include the interaction of CD28 with its ligands CD80 and CD86. These signals are delivered by antigen presenting cells (APC) in the context of the immunological synapse